Bojarski AJ - Search Results

1

Structure-activity relationships and molecular studies of novel arylpiperazinylalkyl purine-2,4-diones and purine-2,4,8-triones with antidepressant and anxiolytic-like activity.

Zagórska A, Kołaczkowski M, Bucki A, Siwek A, Kazek G, Satała G, Bojarski AJ, Partyka A, Wesołowska A, Pawłowski M. Zagórska A, et al. Among authors: bojarski aj. Eur J Med Chem. 2015 Jun 5;97:142-54. doi: 10.1016/j.ejmech.2015.04.046. Epub 2015 May 1. Eur J Med Chem. 2015. PMID: 25965777

2

Structure-activity relationship studies of CNS agents. Part III. On the bioactive conformations of 1-arylpiperazines at 5-HT1A receptor.

Mokrosz JL, Duszyńska B, Bojarski A. Mokrosz JL, et al. Pol J Pharmacol Pharm. 1992 Jan-Feb;44(1):87-97. Pol J Pharmacol Pharm. 1992. PMID: 1359516

3

Structure-activity relationship studies of CNS agents, Part 25. 4,6-di(heteroaryl)-2-(N-methylpiperazino)pyrimidines as new, potent 5-HT2A receptor ligands: a verification of the topographic model.

Mokrosz MJ, Strekowski L, Kozak WX, Duszyńska B, Bojarski AJ, Kłodzinska A, Czarny A, Cegła MT, Dereń-Wesoøek A, Chojnacka-Wójcik E, et al. Mokrosz MJ, et al. Among authors: bojarski aj. Arch Pharm (Weinheim). 1995 Sep;328(9):659-66. doi: 10.1002/ardp.19953280906. Arch Pharm (Weinheim). 1995. PMID: 7487423

4

Structure-activity relationship studies of CNS agents--XVII. Spiro[piperidine-4',1-(1,2,3,4-tetrahydro-beta-carboline)] as a probe defining the extended topographic model of 5-HT1A receptors.

Mokrosz MJ, Duszynska B, Bojarski AJ, Mokrosz JL. Mokrosz MJ, et al. Among authors: bojarski aj. Bioorg Med Chem. 1995 May;3(5):533-8. doi: 10.1016/0968-0896(95)00039-j. Bioorg Med Chem. 1995. PMID: 7648202

5

Structure-activity relationship studies of CNS agents, XIX: Quantitative analysis of the alkyl chain effects on the 5-HT1A and 5-HT2 receptor affinities of 4-alkyl-1-arylpiperazines and their analogs.

Mokrosz JL, Mokrosz MJ, Charakchieva-Minol S, Paluchowska MH, Bojarski AJ, Duszyńska B. Mokrosz JL, et al. Among authors: bojarski aj. Arch Pharm (Weinheim). 1995 Feb;328(2):143-8. doi: 10.1002/ardp.19953280210. Arch Pharm (Weinheim). 1995. PMID: 7726740

6

Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.

Mokrosz JL, Strekowski L, Duszyńska B, Harden DB, Mokrosz MJ, Bojarski AJ. Mokrosz JL, et al. Among authors: bojarski aj. Pharmazie. 1994 Nov;49(11):801-6. Pharmazie. 1994. PMID: 7838864

7

8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.

Mokrosz JL, Dereń-Wesołek A, Tatarczyńska E, Duszyńska B, Bojarski AJ, Mokrosz MJ, Chojnacka-Wójcik E. Mokrosz JL, et al. Among authors: bojarski aj. J Med Chem. 1996 Mar 1;39(5):1125-9. doi: 10.1021/jm950662c. J Med Chem. 1996. PMID: 8676348

8

1,2,3,4-tetrahydroisoquinoline derivatives: a new class of 5-HT1A receptor ligands.

Mokrosz MJ, Bojarski AJ, Duszyńska B, Tatarczyńska E, Kłodzińska A, Dereń-Wesołek A, Charakchieva-Minol S, Chojnacka-Wójcik E. Mokrosz MJ, et al. Among authors: bojarski aj. Bioorg Med Chem. 1999 Feb;7(2):287-95. doi: 10.1016/s0968-0896(98)00238-7. Bioorg Med Chem. 1999. PMID: 10218820

9

On the bioactive conformation of NAN-190 (1) and MP3022 (2), 5-HT(1A) receptor antagonists.

Paluchowska MH, Mokrosz MJ, Bojarski A, Wesołowska A, Borycz J, Charakchieva-Minol S, Chojnacka-Wójcik E. Paluchowska MH, et al. J Med Chem. 1999 Dec 2;42(24):4952-60. doi: 10.1021/jm991045h. J Med Chem. 1999. PMID: 10585205

10

Structure-activity relationship studies of CNS agents. Part 38. Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities.

Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Bojarski AJ, Fruziński A, Karolak-Wojciechowska J, Wesołowska A, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Mokrosz MJ, et al. Among authors: bojarski aj. Arch Pharm (Weinheim). 1999 Nov;332(11):373-9. doi: 10.1002/(sici)1521-4184(199911)332:11<373::aid-ardp373>3.0.co;2-l. Arch Pharm (Weinheim). 1999. PMID: 10605377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page